top of page

100XBIO is on a mission
o advance T cell therapy
by simplifying tools for testing T cell response

100XBIO main product is a technology for 

multiplex antigen-specific T cell activation detection

Contact us:


Timeline 4 Steps (Layout 4x1) (1)_edited.jpg

Up to 100 cycles of antigen-specific stimulation

Get 100X more data from the same small samples!

cycles of live T cell imaging after antigen-specific peptide activation through T cell receptor.

We re-test T cells instead of wasting like in conventional ELISpot assays.  
Live T cells could be analyzed by FACS or sequencing downstream.


For personalized cancer vaccines, validate 40 individual neoantigen targets in less than 24 hours
Screenshot 2024-01-17 at
personalized neoantigen epitope prediction
Screenshot 2024-01-22 at 11.27.21.png
Screenshot 2024-01-17 at 16.48_edited.jpg
neoantigen epitope validation in vitro on patient's T cells
personalized vaccine injection
photo_2024-01-18 12.48_edited.jpg

Subscribe to Learn More:

Thanks for subscribing!

bottom of page